S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
DRIO · DarioHealth Corp.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$3.58
-0.46
(-11.29%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$3.58
$3.15
$3.96
52-WEEK RANGE
$3.58
$3.85
$16.50
What's happening
- DRIO is down 11.29% today, trading at $3.58. — Live quote
- It's trading within 3% of its 52-week low ($3.85). (Finnhub fundamentals)
- Volume today (4,429) is well below its 3-month average of 23,300. (Finnhub fundamentals)
- Reports earnings on 2026-11-11 (before market open), 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.85 actual vs. $-1.24 estimated (+31.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 6
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
DRIO
-64.15%
vs S&P 500
-76.72%
1-YEAR RETURN
DRIO
-68.69%
vs S&P 500
-83.25%
6-MONTH RETURN
DRIO
-41.96%
3-MONTH RETURN
DRIO
-41.71%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.85
Est. $-1.24
BEAT +31.4%
2026-04-26 (Q1 2026)
$-1.25
Est. $-1.51
BEAT +17.2%
2026-01-26 (Q4 2025)
$-3.43
Est. $-3.31
MISS -3.7%
2025-10-26 (Q3 2025)
$2.96
Est. $-5.00
BEAT +159.2%
Valuation Measures & Ratios
Enterprise Value4$55.6M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1.83
Price / Book70.88
EV4 / Revenue2.65
EV4 / EBITDA—
Profit Margin-169.87%
Operating Margin-151.60%
Return on Equity (ROE8)-54.81%
Return on Assets (ROA9)-33.36%
Avg Volume (3M)23,300
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short81,615
Change from Prior Settlement+4.39%
% of Float—
Days to Cover (Short Ratio)4.41
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-09-28; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -3.6% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -169.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is -68.7%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on DRIO
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | $3.2M | $3.2M | $3.0M | $3.0M | $3.9M | $3.9M | $2.8M | $2.4M |
| Operating income | -$6.5M | -$7.3M | -$9.5M | -$9.2M | -$9.4M | -$12.0M | -$16.2M | -$17.9M |
| Net income | -$7.9M | -$8.2M | -$10.5M | -$13.0M | -$9.2M | -$12.3M | -$13.6M | -$7.2M |
| EPS (diluted) | $0.85 | $1.25 | $2.96 | $3.54 | $2.87 | $4.91 | $0.08 | $0.20 |
| EPS (basic) | $0.85 | $1.25 | $2.96 | $3.54 | $2.87 | $4.91 | $0.08 | $0.20 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $96.6M | $103.3M | $110.1M | $117.7M | $108.3M | $115.6M | $118.9M | $110.0M |
| Stockholders' equity | $55.1M | $62.4M | $67.9M | $74.9M | $64.0M | $73.7M | $72.0M | $58.5M |
| Total current assets | $22.1M | $28.7M | $35.1M | $42.2M | $32.2M | $38.6M | $40.5M | $29.5M |
| Total current liabilities | $9.6M | $9.4M | $9.3M | $9.3M | $9.8M | $19.2M | $16.6M | $18.8M |
| Cash & equivalents | $6.6M | $15.0M | $21.8M | $31.9M | $22.0M | $27.9M | $27.8M | $15.5M |
| Marketable securities (current) | $7.3M | $5.0M | $4.2M | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | $3.7M | $4.2M | $4.3M | $4.9M | $4.6M | $4.6M | $4.8M | $4.7M |
| Other current assets | — | — | $527.0K | — | — | — | $289.0K | — |
| Property, plant & equipment | $503.0K | $511.0K | $549.0K | $578.0K | $610.0K | $646.0K | $709.0K | $1.2M |
| Goodwill | $57.4M | $57.4M | $57.4M | $57.4M | $57.4M | $57.4M | $57.4M | $57.4M |
| Intangible assets | $15.0M | $15.5M | $15.9M | $16.4M | $16.9M | $17.6M | $18.8M | $20.3M |
| Accrued liabilities | — | — | $2.4M | — | — | — | $1.9M | — |
| Deferred revenue (current) | $521.0K | $501.0K | $714.0K | $860.0K | $727.0K | $1.3M | $1.6M | $1.1M |
| Short-term debt | — | — | — | — | — | $10.3M | $5.5M | $8.7M |
| Long-term debt | $31.1M | $30.9M | $30.7M | $30.6M | $30.5M | $18.9M | $23.5M | $20.2M |
| Other non-current liabilities | $68.0K | $83.0K | $46.0K | $74.0K | $81.0K | $91.0K | $25.0K | $49.0K |
| Common stock & paid-in capital | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K |
| Retained earnings | -$468.3M | -$460.3M | -$452.1M | -$441.8M | -$423.0M | -$404.4M | -$390.3M | -$378.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.1M | -$6.0M | -$5.9M | -$7.3M | -$6.0M | -$6.7M | -$6.7M | -$7.4M |
| Investing cash flow | -$2.3M | -$826.0K | -$4.2M | -$41.0K | -$44.0K | -$31.0K | -$21.0K | -$32.0K |
| Financing cash flow | — | — | -$19.0K | $17.4M | $124.0K | $6.8M | $18.3M | $0 |
| Free cash flow | -$6.1M | -$6.1M | -$5.9M | -$7.4M | -$6.1M | -$6.7M | -$6.8M | -$7.4M |
| Capital expenditures | $38.0K | $31.0K | $26.0K | $41.0K | $44.0K | $31.0K | $21.0K | $32.0K |
| Share-based compensation | — | — | — | — | — | — | $46.0K | — |
| Deferred income taxes | — | — | — | — | — | — | -$2.0M | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in inventory | -$453.0K | -$144.0K | -$554.0K | $260.0K | -$13.0K | -$130.0K | $12.0K | -$391.0K |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | $0 | $0 | $31.5M | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | $12.7M | $13.3M | $6.0M | $9.7M | $4.0M |
| Operating income | -$36.7M | -$57.7M | -$56.2M | -$56.8M | -$76.5M |
| Net income | -$41.7M | -$42.7M | -$59.4M | -$62.2M | -$76.8M |
| EPS (diluted) | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 |
| EPS (basic) | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $110.1M | $118.9M | $96.4M | $119.2M | $100.8M |
| Stockholders' equity | $67.9M | $72.0M | $58.1M | $80.0M | $85.5M |
| Total current assets | $35.1M | $40.5M | $47.3M | $65.5M | $45.6M |
| Total current liabilities | $9.3M | $16.6M | $12.5M | $19.4M | $14.4M |
| Cash & equivalents | $21.8M | $27.8M | $36.8M | $49.4M | $35.8M |
| Marketable securities (current) | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — |
| Inventory | $4.3M | $4.8M | $5.1M | $8.0M | $6.2M |
| Other current assets | $527.0K | $289.0K | $250.0K | $239.0K | $76.0K |
| Property, plant & equipment | $549.0K | $709.0K | $899.0K | $788.0K | $702.0K |
| Goodwill | $57.4M | $57.4M | $41.6M | $41.6M | $41.6M |
| Intangible assets | $15.9M | $18.8M | $5.4M | $9.9M | $12.5M |
| Accrued liabilities | $2.4M | $1.9M | $2.2M | $2.2M | $4.4M |
| Deferred revenue (current) | $714.0K | $1.6M | $997.0K | $1.3M | $1.2M |
| Short-term debt | — | $5.5M | $4.0M | $8.8M | — |
| Long-term debt | $30.7M | $23.5M | $24.6M | $18.1M | $0 |
| Other non-current liabilities | $46.0K | $25.0K | $36.0K | $0 | — |
| Common stock & paid-in capital | $4.0K | $4.0K | $3.0K | $3.0K | $2.0K |
| Retained earnings | -$452.1M | -$390.3M | -$349.4M | -$285.9M | -$222.0M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$25.9M | -$38.6M | -$30.4M | -$47.8M | -$50.4M |
| Investing cash flow | -$4.3M | -$8.9M | -$547.0K | -$573.0K | -$8.1M |
| Financing cash flow | $24.3M | $38.5M | $18.3M | $61.9M | $65.8M |
| Free cash flow | -$26.1M | -$38.7M | -$31.0M | -$48.3M | -$50.7M |
| Capital expenditures | $142.0K | $138.0K | $584.0K | $442.0K | $261.0K |
| Share-based compensation | — | $46.0K | — | — | — |
| Deferred income taxes | — | -$2.0M | — | — | — |
| Change in inventory | -$437.0K | -$308.0K | -$2.9M | $1.7M | $2.2M |
| Purchases of investments | — | — | — | — | — |
| Share repurchases | — | — | — | $134.0K | — |
| Debt repaid | $31.5M | — | $27.8M | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding DRIO as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-08-12 to 2026-09-24
Recent transactions
- Insiders have net bought 14,430 shares over the last 182 days, across 1 purchase and 0 sales.
- Most recent: PALUMBO JOHN R (Director) — Grant / award of 62,000 shares on 2026-09-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)14,430 sh(1 txns)
Sales (open market)0 sh(0 txns)
Net Shares+14,430
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| PALUMBO JOHN R | Director | Grant / award | 2026-09-24 | 62,000 |
| STERN ADAM K | Director | Grant / award | 2026-09-24 | 28,000 |
| MCGRATH DENNIS M | Director | Grant / award | 2026-09-24 | 61,000 |
| Shaked Yoav | Director | Grant / award | 2026-09-24 | 54,000 |
| Franco-Yehuda Chen | Chief Financial Officer | Grant / award | 2026-09-24 | 95,000 |
| Matheis Dennis | Director | Grant / award | 2026-09-24 | 44,000 |
| Karah Hila | Director | Grant / award | 2026-09-24 | 28,000 |
| Raphael Erez | Chief Executive Officer | Grant / award | 2026-09-24 | 297,000 |
| Nelson Steven Charles | President and CCO | Grant / award | 2025-09-11 | 30,000 |
| Leisure Lawrence B. | Director | Grant / award | 2025-09-11 | 20,000 |
| KAPLAN JON H. | Director | Grant / award | 2025-02-24 | 30,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | PALUMBO JOHN R | Director | Grant / award | 62,000 | $0.00 |
| 2026-09-24 | STERN ADAM K | Director | Grant / award | 28,000 | $0.00 |
| 2026-09-24 | MCGRATH DENNIS M | Director | Grant / award | 61,000 | $0.00 |
| 2026-09-24 | Shaked Yoav | Director | Grant / award | 54,000 | $0.00 |
| 2026-09-24 | Franco-Yehuda Chen | Chief Financial Officer | Grant / award | 95,000 | $0.00 |
| 2026-09-24 | Matheis Dennis | Director | Grant / award | 44,000 | $0.00 |
| 2026-09-24 | Karah Hila | Director | Grant / award | 28,000 | $0.00 |
| 2026-09-24 | Raphael Erez | Chief Executive Officer | Grant / award | 297,000 | $0.00 |
| 2026-07-23 | Matheis Dennis | Director | Open market purchase | 14,430 | $6.93 |
| 2025-09-18 | STERN ADAM K | Director | Derivative conversion | 11,760 | $40.40 |
| 2025-09-18 | STERN ADAM K | Director | Derivative conversion | 8,435 | $16.60 |
| 2025-09-11 | Nelson Steven Charles | President and CCO | Grant / award | 30,000 | $0.00 |
| 2025-09-11 | STERN ADAM K | Director | Grant / award | 20,000 | $0.00 |
| 2025-09-11 | Leisure Lawrence B. | Director | Grant / award | 20,000 | $0.00 |
| 2025-09-11 | Shaked Yoav | Director | Grant / award | 20,000 | $0.00 |
| 2025-09-11 | Raphael Erez | Chief Executive Officer | Grant / award | 60,000 | $0.00 |
| 2025-09-11 | Franco-Yehuda Chen | Chief Financial Officer | Grant / award | 5,000 | $0.00 |
| 2025-09-11 | MCGRATH DENNIS M | Director | Grant / award | 20,000 | $0.00 |
| 2025-09-11 | Karah Hila | Director | Grant / award | 20,000 | $0.00 |
| 2025-09-11 | Matheis Dennis | Director | Grant / award | 20,000 | $0.00 |
| 2025-08-27 | Nelson Steven Charles | President and CCO | Open market purchase | 40,000 | $0.53 |
| 2025-05-15 | Franco-Yehuda Chen | Chief Financial Officer | Grant / award | 500,000 | $0.00 |
| 2025-02-24 | KAPLAN JON H. | Director | Grant / award | 30,000 | $0.00 |
| 2024-11-12 | Nelson Steven Charles | Chief Commercial Officer | Open market purchase | 5,000 | $0.91 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:55 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-28 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-28 | 4 | 2025-09-18 | View on SEC.gov → |
| 2026-09-28 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-28 | 4 | 2024-08-12 | View on SEC.gov → |
| 2026-09-28 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-28 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-28 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-28 | 4 | 2024-08-12 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-09-02 | View on SEC.gov → |
| 2026-08-21 | 8-K | 2026-08-20 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-28 | 4 | 2024-08-12 | View on SEC.gov → |
Recent news
Headlines about DRIO (DarioHealth Corp.). Links open the publisher — we don’t host full articles.
-
DarioHealth reports Aon savings review: what it means for DarioHealth stock
AD HOC NEWS · 2026-10-21 -
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2026-10-20 -
How (DRIO) Movements Inform Risk Allocation Models
Stock Traders Daily · 2026-10-18 -
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
Yahoo Finance · 2026-10-06 -
DarioHealth wins New Jersey health plan contract covering 1.5M lives
Seeking Alpha · 2026-09-17 -
Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives
Yahoo Finance · 2026-09-17 -
DarioHealth (DRIO) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-12 -
DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ...
Yahoo Finance · 2026-08-11
No headlines in this category right now — try “All”.